On July 1, Massachusetts launched perhaps the most ambitious effort yet by any state to provide healthcare to all of its citizens. The health plan was passed with strong bipartisan support, including the support of then-Gov. Mitt Romney. For months, residents of Massachusetts have seen one report after another by critics warning that the health plan will bankrupt the state, that it can never work, that poor people won’t be able to afford their premiums—and all manner of other dire consequences. So do the citizens of Massachusetts support their plan? Or are they starting to thing they made a big mistake? And what do doctors think?
Massachusetts' New Health Plan: Who Likes It?
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
On July 1, Massachusetts launched perhaps the most ambitious effort yet by any state to provide healthcare to all of its citizens. The health plan was passed with strong bipartisan support, including the support of then-Gov. Mitt Romney. For months, residents of Massachusetts have seen one report after another by critics warning that the health plan will bankrupt the state, that it can never work, that poor people won’t be able to afford their premiums—and all manner of other dire consequences. So do the citizens of Massachusetts support their plan? Or are they starting to thing they made a big mistake? And what do doctors think?
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
FCS and SHTG: Are We Meeting the Need?
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement
Best Practices for Identifying, Diagnosing and Treating Transthyretin Amyloidosis (ATTR-PN and ATTR-CM)
Challenges in AI-Driven Dermatology: Understanding Current Limitations
Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF
Effect of Finerenone on NT-proBNP in HFmrEF/HFpEF: FINEARTS-HF Trial
Semaglutide improves walking distance, symptoms and QoL in patients with PAD and T2D
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?